[Coronary Angioplasty and Stenting in Patients Older Than 80 Years: Immediate and Long-Term Results]

A M Babunashvili1, D P Dundua1, D S Kartashov1

  • 1Multidisciplinary Clinic Center of Endosurgery and Lithotripsy, Moscow, Russia.

Kardiologiia
|March 15, 2017
PubMed

Insights

Coronary angioplasty and stenting effectively treats coronary atherosclerosis in patients over 80. Radial access reduces complications, making it a safe option for this high-risk group.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Cardiology

Background:

  • Elderly patients (>80 years) represent a high-risk group for coronary artery disease due to comorbidities and advanced atherosclerosis.
  • Percutaneous coronary intervention (PCI) outcomes in this specific demographic require careful evaluation.

Purpose of the Study:

  • To assess the immediate and long-term efficacy and safety of coronary angioplasty and stenting in patients aged 80 and above.
  • To identify predictors of major adverse cardiac events (MACE) in this elderly population.

Main Methods:

  • Retrospective analysis of 167 patients over 80 years old who underwent PCI between 2006 and 2013.
  • Detailed assessment of patient demographics, lesion characteristics, procedural details, and outcomes including angiographic success, clinical events, and mortality.
  • Long-term follow-up utilizing questioning, control angiography, and echocardiography.

Main Results:

  • High rates of immediate angiographic (97%) and clinical success (94%) were achieved.
  • Hospital mortality was low (0.7%), with 30-day and >24-month MACE rates of 4.6% and 22.4%, respectively.
  • Predictors of remote MACE included depressed left ventricular function, diabetes mellitus, and lesion length >35 mm. Radial access showed a lower rate of access-related complications (1.9%).

Conclusions:

  • Coronary angioplasty and stenting are effective treatments for coronary atherosclerosis in octogenarians, with an acceptable MACE rate.
  • Transradial access is associated with fewer vascular complications in this high-risk elderly cohort.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
465
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
358
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
448
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538